GGrantIndex
Sort

50,496 grants matching lung cancer

Western New York Cancer Coalition (WNYC2) Center to Reduce Disparities

$714,278
Willie Underwood · Roswell Park Cancer Institute Corp · U54 · FY2013 · CA

Craniofacial Developmental Dynamics

$714,249
Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2010 · DE

Late Effects of Treatment in Wilms Tumor Survivors and Offspring

$714,157
Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA

Novel Targets for Vaccine Therapy

$714,123
Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

The biological mechanisms of racial disparity in head and neck cancer

$714,062
Fatemeh Momen Heravi · University Of California, San Francisco · R01 · FY2025 · CA

Clinical Efficacy Evaluation of First-in-class Imipridone ONC201 in Recurrent Type II Endometrial Cancer

$714,000
Wolfgang Oster · Oncoceutics, Inc. · R44 · FY2018 · CA

BIOMARKERS OF EXPOSURE AND EFFECT IN A TRAFFIC EXPOSED POPULATION

$713,888
Francine Laden · Brigham And Women'S Hospital · R01 · FY2010 · ES

LTRC CLINICAL CENTER

$713,712
Frank C. Sciurba · University Of Pittsburgh At Pittsburgh · N01 · FY2011 · HL

Arsenic co-carcinogenesis with UVR: nitrosation and oxidation of target proteins

$713,661
Ke Jian Liu · University Of New Mexico Health Scis Ctr · R01 · FY2016 · ES

NanoCytology to mitigate overdiagnosis of prostate cancer

$713,412
Hariharan Subramanian · Nanocytomics, Llc · R44 · FY2016 · CA

Development and Translation of Generator-Produced PET Tracer for Myocardial Perfusion Imaging

$713,323
Vijay Sharma · Washington University · R01 · FY2022 · HL

Genetic Susceptibility to Lung Cancer

$713,147
Harvard University (Sch Of Public Hlth) · R01 · FY2003 · CA

Provider Support and Patient Outreach in Lung Cancer Screening

$713,095
Ronald E Myers · Thomas Jefferson University · R01 · FY2022 · CA

Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer

$713,044
Ming You · Methodist Hospital Research Institute · R01 · FY2021 · CA

Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors

$712,969
Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA

Ten-Fold Resolution Boost for Magnetic Particle Imaging with Applications to Rapid, Non-Invasive Imaging of CAR-T Cell Therapies, Stroke, GI Bleeds and Pulmonary Embolisms

$712,953
Steven M Conolly · University Of California Berkeley · U01 · FY2023 · EB

PARTNERSHIP FOR RESEARCH IN OPTICAL COHERENCE TOMOGRAPHY

$712,945
Duke University · R24 · FY2003 · EB

Development of Novel Targeted Chemotherapeutics for the Treatment ofMalignant Pleural Mesothelioma

$712,873
Frank L Sorgi · Flag Therapeutics, Inc. · R44 · FY2018 · CA

LTRC CLINICAL CENTER

$712,833
Frank C. Sciurba · University Of Pittsburgh At Pittsburgh · N01 · FY2012 · HL

A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma

$712,796
Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma

$712,796
Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

CANCER PREVENTION AND CONTROL TRAINING GRANT

$712,733
University Of Arizona · R25 · FY2001 · CA

Small molecule enhancers of tumor immunity targeting the LPA5 GPCR

$712,726
Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2024 · CA

Predictors and Consequences of Combustible Cigarette Smokers' Switch to Standardized Research E-Cigarettes

$712,673
Robin J Mermelstein · University Of Illinois At Chicago · U01 · FY2018 · DA

Impact of Macrophage Carbon Load and Epigenetic Aging on Lung Function Decline and Mortality

$712,649
Shuguang Leng · University Of New Mexico Health Scis Ctr · R01 · FY2025 · ES